Analystreport

Coherus Biosciences Inc (NASDAQ: CHRS) was upgraded by analysts at TheStreet from a "d+" rating to a "c-" rating.

Coherus BioSciences, Inc.  (CHRS) 
Last coherus biosciences, inc. earnings: 2/27 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.coherus.com